1. Home
  2. XNCR vs HMN Comparison

XNCR vs HMN Comparison

Compare XNCR & HMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • HMN
  • Stock Information
  • Founded
  • XNCR 1997
  • HMN 1945
  • Country
  • XNCR United States
  • HMN United States
  • Employees
  • XNCR N/A
  • HMN N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • HMN Property-Casualty Insurers
  • Sector
  • XNCR Health Care
  • HMN Finance
  • Exchange
  • XNCR Nasdaq
  • HMN Nasdaq
  • Market Cap
  • XNCR 547.8M
  • HMN 1.9B
  • IPO Year
  • XNCR 2013
  • HMN 1991
  • Fundamental
  • Price
  • XNCR $10.03
  • HMN $46.33
  • Analyst Decision
  • XNCR Buy
  • HMN Buy
  • Analyst Count
  • XNCR 10
  • HMN 5
  • Target Price
  • XNCR $20.22
  • HMN $46.75
  • AVG Volume (30 Days)
  • XNCR 862.2K
  • HMN 200.7K
  • Earning Date
  • XNCR 11-05-2025
  • HMN 11-03-2025
  • Dividend Yield
  • XNCR N/A
  • HMN 3.06%
  • EPS Growth
  • XNCR N/A
  • HMN 71.62
  • EPS
  • XNCR N/A
  • HMN 3.38
  • Revenue
  • XNCR $146,929,000.00
  • HMN $1,649,200,000.00
  • Revenue This Year
  • XNCR $23.31
  • HMN $7.38
  • Revenue Next Year
  • XNCR N/A
  • HMN $6.25
  • P/E Ratio
  • XNCR N/A
  • HMN $13.54
  • Revenue Growth
  • XNCR N/A
  • HMN 6.01
  • 52 Week Low
  • XNCR $6.92
  • HMN $33.97
  • 52 Week High
  • XNCR $27.24
  • HMN $47.81
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 74.51
  • HMN 56.17
  • Support Level
  • XNCR $8.49
  • HMN $45.44
  • Resistance Level
  • XNCR $8.73
  • HMN $47.81
  • Average True Range (ATR)
  • XNCR 0.46
  • HMN 0.82
  • MACD
  • XNCR 0.16
  • HMN -0.18
  • Stochastic Oscillator
  • XNCR 94.02
  • HMN 38.84

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About HMN Horace Mann Educators Corporation

Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are 403(b) tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.

Share on Social Networks: